出入境政策優化!港股旅遊觀光股集體走強,香港中旅漲超8%
格隆匯12月28日丨香港中旅漲超8%,縱橫遊控股漲超5%,專業旅運漲超4%,攜程集團漲近4%,同程旅行漲超2%,中國中免漲1%。國家衞健委26日晚發佈《關於對新型冠狀病毒感染實施“乙類乙管”的總體方案》。將新冠肺炎更名為新冠感染,1月8日起實施“乙類乙管”。取消入境後全員核酸檢測和集中隔離,有序恢復中國公民出境旅遊。國家移民管理局自2023年1月8日起優化移民管理政策措施。有序恢復受理審批中國公民因出國旅遊、訪友申請普通護照,恢復辦理內地居民旅遊、商務赴港簽註。多個疫情前大熱的出境目的地,在2023兔年春節時段的搜索熱度開始顯著增長。數據顯示,中國澳門、中國香港、日本、泰國、韓國、美國、新加坡、馬來西亞、澳大利亞和英國,成為搜索量增長最快的前十名目的地。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.